Supreme Court Denies Review Of Patent-Term Calculation Case
WASHINGTON, D.C. — Allegations that the U.S. Patent and Trademark Office (PTO) erroneously calculated the patent-term adjustments for three pharmaceutical patents will not be heard by the U.S. Supreme Court, which...To view the full article, register now.
Already a subscriber? Click here to view full article